Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 640 of 1,261

  1. US 9616136

    N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides

    Nektar Therapeutics · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  2. US 9616099

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  3. US 9616102

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  4. US 9616073

    Method for on-demand contraception

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  5. US 9616090

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Biosciences, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  6. US 9616076

    Methods for treating viral infections using hydrogen sulfide donors

    The Board of Regents of the University of Texas System · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  7. US 9615758

    Contribution of oxidative stress to AF electrograms

    Northwestern University · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  8. US 9616060

    Particulate materials

    Nektar Therapeutics · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  9. US 9616015

    Formulations of human tissue kallikrein-1 for parenteral delivery and related methods

    DiaMedica Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  10. US 9618514

    Methods of evaluating patients using E-cadherin and vimentin

    Agios Pharmaceuticals, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  11. US 9617541

    Biocompatible infinite coordination polymer nanoparticle-nucleic acid conjugates for antisense gene regulation

    Northwestern University · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  12. US 9617526

    Mutated organophosphorus acid anhydrolases and their uses thereof

    The United States of America as represented by the Secretary of the Army · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  13. US 9617596

    Biomarkers predictive for clinical response for glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  14. US 9618513

    Compositions and methods for detecting and treating colorectal cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  15. US 9617540

    Compounds and methods for modulating gene expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 11, 2017 · Expires Apr 6, 2037

    granted

  16. US 9610278

    Glycopyrrolate salts

    Dermira, Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  17. US 9610358

    Targeted pharmacological chaperones

    Marker Gene Technologies, Inc · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  18. US 9610320

    Surgical applications for BMP binding protein

    The Regents of the University of California · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  19. US 9610338

    Serologic correlates of protection against bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  20. US 9611456

    Progenitor cells from wharton'S jelly of human umbilical cord

    Tissue Regeneration Therapeutics Inc. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  21. US 9611292

    Peptide inhibitors of serotonin 5-HT2c receptors:PTEN interaction

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  22. US 9611266

    Compounds and anti-tumor NQO1 substrates

    The Board of Regents of the University of Texas System · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  23. US 9609883

    Method for producing wheat glutamine peptide

    CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

  24. US 9611258

    Dual MEK/PI3K inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 4, 2017 · Expires Mar 30, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.